124 related articles for article (PubMed ID: 8477413)
1. Encephalopathy associated with bismuth subgallate therapy.
Friedland RP; Lerner AJ; Hedera P; Brass EP
Clin Neuropharmacol; 1993 Apr; 16(2):173-6. PubMed ID: 8477413
[TBL] [Abstract][Full Text] [Related]
2. Bismuth Subgallate Toxicity in the Age of Online Supplement Use.
Sampognaro P; Vo KT; Richie M; Blanc PD; Keenan K
Neurologist; 2017 Nov; 22(6):237-240. PubMed ID: 29095326
[TBL] [Abstract][Full Text] [Related]
3. Respiratory difficulty following bismuth subgallate aspiration.
Murray AD; Gibbs SR; Billings KR; Biavati MJ
Arch Otolaryngol Head Neck Surg; 2000 Jan; 126(1):79-81. PubMed ID: 10628716
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of bismuth subgallate. A further report from the Australian Drug Evaluation Committee.
Lowe DJ
Med J Aust; 1974 Nov; 2(18):664-6. PubMed ID: 4453225
[No Abstract] [Full Text] [Related]
5. Does bismuth subgallate have haemostatic effects in tonsillectomy?
Sørensen WT; Henrichsen J; Bonding P
Clin Otolaryngol Allied Sci; 1999 Feb; 24(1):72-4. PubMed ID: 10196655
[TBL] [Abstract][Full Text] [Related]
6. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent.
Thorisdottir H; Ratnoff OD; Maniglia AJ
J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356
[TBL] [Abstract][Full Text] [Related]
7. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
[TBL] [Abstract][Full Text] [Related]
8. Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters.
Molina JA; Calandre L; Bermejo F
Acta Neurol Scand; 1989 Mar; 79(3):200-3. PubMed ID: 2566254
[TBL] [Abstract][Full Text] [Related]
9. Bismuth subgallate--its role in tonsillectomy.
Fenton JE; Blayney AW; O'Dwyer TP
J Laryngol Otol; 1995 Mar; 109(3):203-5. PubMed ID: 7745334
[TBL] [Abstract][Full Text] [Related]
10. Mental illness or metal illness? Bismuth subgallate.
Robertson JF
Med J Aust; 1974 Jun; 1(22):887-8. PubMed ID: 4853162
[No Abstract] [Full Text] [Related]
11. Bismuth subgallate-epinephrine paste in adenotonsillectomies.
Hatton RC
Ann Pharmacother; 2000 Apr; 34(4):522-5. PubMed ID: 10772440
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary sequelae of intraparenchymal bismuth subgallate.
Cozzi LM; Megerian CA; Dugue C; Barcello M; Abdul-Karim FW; Arnold JE; Maniglia AJ
Laryngoscope; 1992 Jun; 102(6):597-9. PubMed ID: 1602906
[TBL] [Abstract][Full Text] [Related]
13. Effect of bismuth subgallate on the quality of life in patients undergoing Scopinaro's biliopancreatic diversion.
Hernández JR; Rizzo JF; Díaz YC; Bubi ED; Cabrillana JM; López-Tomassetti Fernández EM
Surg Obes Relat Dis; 2015; 11(2):436-41. PubMed ID: 25820078
[TBL] [Abstract][Full Text] [Related]
14. Does Bismuth Subgallate Affect Smell and Stool Character? A Randomized Double-Blinded Placebo-Controlled Trial of Bismuth Subgallate on Loop Duodenal Switch Patients with Complaints of Smelly Stools and Diarrhea.
Zaveri H; Surve A; Cottam D; Medlin W; Richards C; Cottam A; Cottam S
Obes Surg; 2018 Nov; 28(11):3511-3517. PubMed ID: 29956108
[TBL] [Abstract][Full Text] [Related]
15. Pitfall-to-avoid pharyngeal opacities caused by bismuth subgallate.
Tannous WN; Azouz EM; Tewfik TL
Can Assoc Radiol J; 1989 Dec; 40(6):312. PubMed ID: 2598077
[TBL] [Abstract][Full Text] [Related]
16. Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats. Histological and histometric findings.
Tramontina VA; Machado MA; Nogueira Filho Gda R; Kim SH; Vizzioli MR; Toledo Sd
Braz Dent J; 2002; 13(1):11-6. PubMed ID: 11870955
[TBL] [Abstract][Full Text] [Related]
17. The influence of bismuth subgallate and adrenaline paste upon operating time and operative blood loss in tonsillectomy.
Callanan V; Curran AJ; Smyth DA; Gormley PK
J Laryngol Otol; 1995 Mar; 109(3):206-8. PubMed ID: 7745335
[TBL] [Abstract][Full Text] [Related]
18. Bismuth subgallate as a topical hemostatic agent at palatal donor sites.
Kim SH; Tramontina VA; Papalexiou V; Luczyszyn SM
Quintessence Int; 2010 Sep; 41(8):645-649. PubMed ID: 20657853
[TBL] [Abstract][Full Text] [Related]
19. Experimental study on the effects of bismuth subgallate on the inflammatory process and angiogenesis of the oral mucosa.
Couto EV; Ballin CR; Sampaio CP; Maeda CA; Ballin CH; Dassi CS; Miura LY
Braz J Otorhinolaryngol; 2016; 82(1):17-25. PubMed ID: 26614041
[TBL] [Abstract][Full Text] [Related]
20. Bismuth subgallate as a topical haemostatic agent at the palatal wounds: a histologic study in dogs.
Kim SH; Tramontina VA; Papalexiou V; Luczsyzyn SM; De Lima AA; do Prado AM
Int J Oral Maxillofac Surg; 2012 Feb; 41(2):239-43. PubMed ID: 22209184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
